I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 銀愷醫藥貿易有限公司 | Official English Name | YINKAI PHARMACEUTICAL TRADING CO., LIMITED |
|---|---|---|---|
Name Evolution
(2 Former Names)
|
2019-12-27
Founding Incorp. Name 信大有限公司HUGE UNITY LIMITED
2020-03-31
Former Name 1 PublicCare U.K Limited
2022-07-06
Current Legal Name 銀愷醫藥貿易有限公司YINKAI PHARMACEUTICAL TRADING CO., LIMITED | ||
| Company Reg No. (CRN) | 2906080 | Business Reg No. (BRN) | 71500447 |
| Incorporation Date | 2019-12-27 | Company Category | Private company limited by shares |
| Current Legal Status | Live | Statutory Filing Cycle | 2026-12-27 |
| Registered Office Address | ROOM A, 12/F, REALITY TOWER, 4 SUN ON STREET, CHAI WAN, HONG KONG | ||
|---|---|---|---|
| Significant Controllers (SCR) | Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report. | ||
II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)
| Document Name | Action |
|---|---|
NR1 Notice of Change of Address of Registered Office | |
NAR1 Annual Return (2022)Latest Shareholders & Directors | |
DOC Certificate of Change of Name | |
NNC2 Notice of Change of Company Name pursuant to Direction (English) | |
NAR1 Annual Return (2021) | |
NAR1 Annual Return (2020) | |
NR1 Notice of Change of Address of Registered Office | |
DOC Certificate of Change of Name | |
NNC2 Notice of Change of Company Name pursuant to Direction (English) | |
NR1 Notice of Change of Address of Registered Office |
III. Commercial Due Diligence & Regulatory Risk Screening
IV. Corporate Statutory Dossier & Legal Status FAQ
What is the official statutory registration status of YINKAI PHARMACEUTICAL TRADING CO., LIMITED in Hong Kong?
Yes. YINKAI PHARMACEUTICAL TRADING CO., LIMITED is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2019-12-27 (operating for 6 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: March 2023).
How to verify the Unique Business Identifier (UBI / BRN) and CRN of YINKAI PHARMACEUTICAL TRADING CO., LIMITED?
The statutory primary identifiers for YINKAI PHARMACEUTICAL TRADING CO., LIMITED are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [71500447] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [2906080] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.
How to verify the Register of Directors, shareholder equity ratios, and Significant Controllers (SCR) of YINKAI PHARMACEUTICAL TRADING CO., LIMITED?
Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.
Has YINKAI PHARMACEUTICAL TRADING CO., LIMITED ever changed its legal company name? What are its former registered names?
Yes. According to the official statutory records of the Hong Kong Companies Registry, YINKAI PHARMACEUTICAL TRADING CO., LIMITED has officially recorded 2 legal name change(s): [HUGE UNITY LIMITED (信大有限公司) (effective 2019-12-27)], [PublicCare U.K Limited (effective 2020-03-31)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.
How to retrieve the certified company registry filings and Form NAR1 of YINKAI PHARMACEUTICAL TRADING CO., LIMITED?
Yes. Statutory indexing confirms that YINKAI PHARMACEUTICAL TRADING CO., LIMITED has accumulated 12 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2023-03-27: Form NR1 - Notice of Change of Address of Registered Office). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.
What is the official registered address of YINKAI PHARMACEUTICAL TRADING CO., LIMITED for legal service of process?
The statutory registered office of YINKAI PHARMACEUTICAL TRADING CO., LIMITED on official record is situated at: [ROOM A, 12/F, REALITY TOWER, 4 SUN ON STREET, CHAI WAN, HONG KONG]. Official registry dossiers also record 3 statutory registered office address change filing(s) (Form NR1). Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.
V. Similar Trade Names & Industry Directory
YINKAI GROUP LIMITED
銀凱集團有限公司
Yinkai Qiyuan Investment Co., Limited
銀凱啟源投資有限公司
Yinkai Limited
茵楷環球有限公司
CHINA PHARMACEUTICAL ENGINEERING GROUP CO., LIMITED
中國制藥工程集團有限公司
CHINA PHARMACEUTICAL CORPORATION LIMITED
中國制藥股份有限公司
CHINA PHARMACEUTICAL DEVELOPMENT CO., LIMITED
中國制藥發展股份有限公司